Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA

Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA

Mega-blockbuster Dupixent was just given the FDA's green light to treat patients with a chronic, progressive inflammatory disease.